Developer docs
API playgroundTry for free, no card

Search company profiles

Solar Biotech

Full company profile

uuid0002pvt

Namestring
Solar Biotech
Legal namestring
Solar Bioprocessing, LLC
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Solar Biotech is a synthetic biology contract development and manufacturing organization (CDMO) founded in 2019, headquartered in Norton, Virginia, and operating through its legal entity Solar Bioprocessing, LLC. The company provides end-to-end bioprocess development, scale-up, and manufacturing services to synthetic biology companies that need to translate lab-scale strain and process work into commercial production. Its integrated offering, marketed as "Synbio Hyperintegration," combines upstream fermentation processing (USP) with downstream processing (DSP) and spans fermentation scales from 6L bench through 125L, 500L, 4,000L, and 10,000L commercial-scale vessels, supported by homogenizers, disc stack centrifuges, MF/UF filtration, and freeze and drum drying on an 18-acre site. Process capabilities extend across at least five industrially relevant host systems: Pichia pastoris, Saccharomyces cerevisiae, filamentous fungi (including the Dyadic C1 expression system), Escherichia coli, and microalgae.

Commercial activity has spanned at least 30 customers across food and beverages, cosmetics, human health and nutraceuticals, agricultural chemicals, and industrial chemicals, producing enzymes, recombinant proteins, specialty oils, cannabinoids and related compounds, carotenoids, yeast biomass, and biopolymers. Revenue is generated on a professional services basis under multi-year, project-based contracts with custom quotations; the company runs a direct enterprise field sales motion, with prospective customers submitting project inquiries through the website. In July 2023, Solar Biotech acquired Noblegen Inc. (Peterborough, Ontario), which now operates as Solar Biotech Canada and extends the company's footprint into Canada with food-grade sustainable ingredient manufacturing. Solar Biotech's disclosed capital history includes a 2021 SEC Form D offering of up to $4 million (of which $2 million was sold at filing) and a 2022 strategic investment from Ingredion Inc. to expand SynBio capabilities and Norton facility capacity. In July 2024, the company filed for Chapter 11 bankruptcy protection and is seeking a strategic buyer for its operating assets, with an initial bid of $15.7 million for certain assets.

Short descriptiontext

Solar Biotech is a Virginia-based synthetic biology CDMO providing end-to-end bioprocess development, scale-up, and contract manufacturing from 6L to 10,000L fermentation across multiple host organisms, serving food, cosmetics, nutraceutical, and industrial customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNorton, United States
HQ citystring
Norton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioprocess development services, contract fermentation manufacturing, synthetic biology CDMO, industrial fermentation services, downstream bioprocessing services
Industry3 codes
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Biomanufacturing (CDMO) Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Bioprocessing and Manufacturing Services
TypeProfessional Services
Description

Solar Biotech provides contract bioprocessing services for synthetic biology product development and commercialization. Services include process development, scale-up, fermentation, and downstream processing for customers across multiple market segments including food-grade enzymes, specialty oils, cannabinoids, carotenoids, and industrial enzymes.

dailydac.com
2Contract Development and Manufacturing Organization (CDMO) Services
TypeProfessional Services
Description

The company operates as a CDMO offering bioprocess development and manufacturing services to synthetic biology companies needing scale-up, process optimization, and production of developmental and commercial quantities. Revenue is generated through project-based contracts and manufacturing campaigns.

solarbiotech.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details1 tier
1Project-based custom pricing based on customer requirements
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing tiers available. Individual project quotes provided based on scope, scale, organisms, product type, and campaign requirements.

solarbiotech.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Solar Biotech operates as a contract development and manufacturing organization (CDMO) for synthetic biology companies, providing end-to-end bioprocess development, fermentation scale-up, and commercial manufacturing services. Its Synbio Hyperintegration platform combines upstream fermentation (6L to 10,000L scale) with full downstream processing under one roof at its 18-acre Norton, Virginia facility. Services span process development, scale-up, and production of enzymes, proteins, specialty oils, cannabinoids, carotenoids, nutraceuticals, and biopolymers across food, cosmetics, nutraceutical, agricultural, and industrial chemical segments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 10+ products shipped to customers
+1 more record
Product overview1 text field

Solar Biotech operates as a unified SynBio biomanufacturing platform called 'Synbio Hyperintegration,' providing end-to-end services from organism development through commercial-scale production. The platform is supported by five interconnected service modules: Upstream Fermentation Processing (USP), Downstream Processing (DSP), Scale-Up and Process Development, and Commercial Manufacturing capabilities spanning 6L to 10,000L fermentation scales. The company also acquired Noblegen in July 2023 (now operating as Solar Biotech Canada), bringing proprietary fermentation technology for sustainable ingredient production. The platform serves diverse market segments including food and beverages, cosmetics, human health and nutraceuticals, agricultural chemicals, and industrial chemicals, producing enzymes, proteins, natural products, fats and oils, and biopolymers.

Product and service1 record
1Upstream Fermentation Processing (USP) Services
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-31
Description

Solar Biotech acquired Noblegen, a Canadian advanced digital biology company based in Ontario, which now operates as Solar Biotech Canada. The acquisition expanded biomanufacturing capacity and expertise in sustainable solutions for diverse microbial applications. Noblegen's proprietary fermentation technology for producing sustainable ingredients was integrated into Solar Biotech's platform. The deal involved Noblegen's transition from water purification to food product biomanufacturing.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Culture Biosciences
TypeDirect peer
Description

Culture Biosciences offers fermentation process development and manufacturing services for synthetic biology companies, directly overlapping Solar Biotech's core CDMO offering across bench to pilot-scale bioreactors.

TypeBroad incumbent
Description

Novonesis (formerly Novozymes) is a global enzyme and microbial protein manufacturer and a frequent source of Solar Biotech's leadership talent, operating at vastly larger scale across overlapping end markets.

TypeDirect peer
Description

Conagen is a synthetic biology CDMO focused on strain engineering and fermentation scale-up for food, beauty, and pharma ingredients—closely comparable to Solar Biotech's USP/DSP services and overlapping with Solar Biotech's management team pedigree.

TypeBroad incumbent
Description

WuXi Biologics is a global contract biologics manufacturer with microbial fermentation capabilities at scale, representing a much larger alternative for customers evaluating CDMO partners in the same segment.

TypeEmerging player
Description

Bota Bio is an emerging synbio CDMO combining strain engineering with fermentation manufacturing for sustainable ingredients, targeting similar customer segments (food, personal care, industrial) as Solar Biotech.

TypeBroad incumbent
Description

Ginkgo Bioworks is a synthetic biology platform company offering cell engineering and bioprocess services to customers across food, industrial, and pharma—competing for the same scale-up demand that Solar Biotech addresses.

TypeDirect peer
Description

Codexis is an enzyme engineering and biocatalysis CDMO serving pharmaceutical and industrial customers with proprietary protein platforms, competing directly with Solar Biotech in industrial enzyme process development and manufacturing.

TypeEmerging player
Description

Dyadic International develops the C1 filamentous fungal expression platform—one of Solar Biotech's named host systems—making it both a potential technology licensor and a peer in industrial biotech manufacturing services.

TypeBroad incumbent
Description

AGC Biologics is a large-scale biologics CDMO offering microbial and mammalian fermentation, competing with Solar Biotech in recombinant protein manufacturing and process development services.

TypeBroad incumbent
Description

Thermo Fisher operates one of the largest CDMO networks globally, including microbial fermentation services, and is a common alumni source for Solar Biotech's commercial team—making it a broad incumbent competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solar Biotech

Contract Biomanufacturing (CDMO) Servicessolarbiotech.com

Solar Biotech is a Virginia-based synthetic biology CDMO providing end-to-end bioprocess development, scale-up, and contract manufacturing from 6L to 10,000L fermentation across multiple host organisms, serving food, cosmetics, nutraceutical, and industrial customers.

What Solar Biotech does

Solar Biotech is a synthetic biology contract development and manufacturing organization (CDMO) founded in 2019, headquartered in Norton, Virginia, and operating through its legal entity Solar Bioprocessing, LLC. The company provides end-to-end bioprocess development, scale-up, and manufacturing services to synthetic biology companies that need to translate lab-scale strain and process work into commercial production. Its integrated offering, marketed as "Synbio Hyperintegration," combines upstream fermentation processing (USP) with downstream processing (DSP) and spans fermentation scales from 6L bench through 125L, 500L, 4,000L, and 10,000L commercial-scale vessels, supported by homogenizers, disc stack centrifuges, MF/UF filtration, and freeze and drum drying on an 18-acre site. Process capabilities extend across at least five industrially relevant host systems: Pichia pastoris, Saccharomyces cerevisiae, filamentous fungi (including the Dyadic C1 expression system), Escherichia coli, and microalgae.

Commercial activity has spanned at least 30 customers across food and beverages, cosmetics, human health and nutraceuticals, agricultural chemicals, and industrial chemicals, producing enzymes, recombinant proteins, specialty oils, cannabinoids and related compounds, carotenoids, yeast biomass, and biopolymers. Revenue is generated on a professional services basis under multi-year, project-based contracts with custom quotations; the company runs a direct enterprise field sales motion, with prospective customers submitting project inquiries through the website. In July 2023, Solar Biotech acquired Noblegen Inc. (Peterborough, Ontario), which now operates as Solar Biotech Canada and extends the company's footprint into Canada with food-grade sustainable ingredient manufacturing. Solar Biotech's disclosed capital history includes a 2021 SEC Form D offering of up to $4 million (of which $2 million was sold at filing) and a 2022 strategic investment from Ingredion Inc. to expand SynBio capabilities and Norton facility capacity. In July 2024, the company filed for Chapter 11 bankruptcy protection and is seeking a strategic buyer for its operating assets, with an initial bid of $15.7 million for certain assets.

Solar Biotech firmographics

Firmographics
Name
Solar Biotech
Legal name
Solar Bioprocessing, LLC
Website
https://solarbiotech.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Solar Biotech is a Virginia-based synthetic biology CDMO providing end-to-end bioprocess development, scale-up, and contract manufacturing from 6L to 10,000L fermentation across multiple host organisms, serving food, cosmetics, nutraceutical, and industrial customers.
Ownership category
akta.pro rank

Solar Biotech industry classification

Industry
Product category
Contract Biomanufacturing (CDMO) Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Bioprocess development services
  • Contract fermentation manufacturing
  • Synthetic biology CDMO
  • Industrial fermentation services
  • Downstream bioprocessing services

Where Solar Biotech is headquartered

Location

Headquarters

HQ city
Norton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Solar Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Bioprocessing and Manufacturing Services: Solar Biotech provides contract bioprocessing services for synthetic biology product development and commercialization. Services include process development, scale-up, fermentation, and downstream processing for customers across multiple market segments including food-grade enzymes, specialty oils, cannabinoids, carotenoids, and industrial enzymes.
  2. Contract Development and Manufacturing Organization (CDMO) Services: The company operates as a CDMO offering bioprocess development and manufacturing services to synthetic biology companies needing scale-up, process optimization, and production of developmental and commercial quantities. Revenue is generated through project-based contracts and manufacturing campaigns.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based custom pricing based on customer requirements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Solar Biotech product offering

Product offering

Core offering

Solar Biotech operates as a contract development and manufacturing organization (CDMO) for synthetic biology companies, providing end-to-end bioprocess development, fermentation scale-up, and commercial manufacturing services. Its Synbio Hyperintegration platform combines upstream fermentation (6L to 10,000L scale) with full downstream processing under one roof at its 18-acre Norton, Virginia facility. Services span process development, scale-up, and production of enzymes, proteins, specialty oils, cannabinoids, carotenoids, nutraceuticals, and biopolymers across food, cosmetics, nutraceutical, agricultural, and industrial chemical segments.

Product overview

Solar Biotech operates as a unified SynBio biomanufacturing platform called 'Synbio Hyperintegration,' providing end-to-end services from organism development through commercial-scale production. The platform is supported by five interconnected service modules: Upstream Fermentation Processing (USP), Downstream Processing (DSP), Scale-Up and Process Development, and Commercial Manufacturing capabilities spanning 6L to 10,000L fermentation scales. The company also acquired Noblegen in July 2023 (now operating as Solar Biotech Canada), bringing proprietary fermentation technology for sustainable ingredient production. The platform serves diverse market segments including food and beverages, cosmetics, human health and nutraceuticals, agricultural chemicals, and industrial chemicals, producing enzymes, proteins, natural products, fats and oils, and biopolymers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Upstream Fermentation Processing (USP) Services

Quantifiable outcome

  • 10+ products shipped to customers
  • +1 more outcomes

Companies that use Solar Biotech

Customer profile

Segments4 records

Ideal customer profiles2 records

Solar Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Solar Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Noblegen Inc. (Acquired)coreStrategic or Co-development Partner · 31 July 2023Solar Biotech acquired Noblegen, a Canadian advanced digital biology company based in Ontario, which now operates as Solar Biotech Canada. The acquisition expanded biomanufacturing capacity and expertise in sustainable solutions for diverse microbial applications. Noblegen's proprietary fermentation technology for producing sustainable ingredients was integrated into Solar Biotech's platform. The deal involved Noblegen's transition from water purification to food product biomanufacturing.

Scale indicators10 records

Recent moves4 records

Expansion highlights5 records

Solar Biotech competitors and assessment

Company assessment

Direct peers

  • Culture Biosciences: Culture Biosciences offers fermentation process development and manufacturing services for synthetic biology companies, directly overlapping Solar Biotech's core CDMO offering across bench to pilot-scale bioreactors.
  • Conagen: Conagen is a synthetic biology CDMO focused on strain engineering and fermentation scale-up for food, beauty, and pharma ingredients—closely comparable to Solar Biotech's USP/DSP services and overlapping with Solar Biotech's management team pedigree.
  • Codexis: Codexis is an enzyme engineering and biocatalysis CDMO serving pharmaceutical and industrial customers with proprietary protein platforms, competing directly with Solar Biotech in industrial enzyme process development and manufacturing.

Broad incumbents

  • Novozymes (Novonesis): Novonesis (formerly Novozymes) is a global enzyme and microbial protein manufacturer and a frequent source of Solar Biotech's leadership talent, operating at vastly larger scale across overlapping end markets.
  • WuXi Biologics: WuXi Biologics is a global contract biologics manufacturer with microbial fermentation capabilities at scale, representing a much larger alternative for customers evaluating CDMO partners in the same segment.
  • Ginkgo Bioworks: Ginkgo Bioworks is a synthetic biology platform company offering cell engineering and bioprocess services to customers across food, industrial, and pharma—competing for the same scale-up demand that Solar Biotech addresses.
  • AGC Biologics: AGC Biologics is a large-scale biologics CDMO offering microbial and mammalian fermentation, competing with Solar Biotech in recombinant protein manufacturing and process development services.
  • Thermo Fisher Scientific (CDMO services): Thermo Fisher operates one of the largest CDMO networks globally, including microbial fermentation services, and is a common alumni source for Solar Biotech's commercial team—making it a broad incumbent competitor.

Emerging players

  • Bota Bio: Bota Bio is an emerging synbio CDMO combining strain engineering with fermentation manufacturing for sustainable ingredients, targeting similar customer segments (food, personal care, industrial) as Solar Biotech.
  • Dyadic International: Dyadic International develops the C1 filamentous fungal expression platform—one of Solar Biotech's named host systems—making it both a potential technology licensor and a peer in industrial biotech manufacturing services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Solar Biotech social profiles

Digital presence

Solar Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solar Biotech leadership team

Management profile

Number of profiles

Profiles6 records

Solar Biotech subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Solar Biotech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solar Biotech M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solar Biotech

What does Solar Biotech do?

Solar Biotech operates as a contract development and manufacturing organization (CDMO) for synthetic biology companies, providing end-to-end bioprocess development, fermentation scale-up, and commercial manufacturing services. Its Synbio Hyperintegration platform combines upstream fermentation (6L to 10,000L scale) with full downstream processing under one roof at its 18-acre Norton, Virginia facility. Services span process development, scale-up, and production of enzymes, proteins, specialty oils, cannabinoids, carotenoids, nutraceuticals, and biopolymers across food, cosmetics, nutraceutical, agricultural, and industrial chemical segments.

Is Solar Biotech a public or private company?

Solar Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was Solar Biotech founded?

Solar Biotech was founded in 2019. It employs 11 to 50 people.

Where is Solar Biotech based?

Solar Biotech is headquartered in Norton, United States, in the North America region.

How does Solar Biotech make money?

Two revenue lines are on record. Bioprocessing and Manufacturing Services are the primary driver. The others are contract Development and Manufacturing Organization (CDMO) Services.

Who are Solar Biotech's main competitors?

Direct peers on record are Culture Biosciences, Conagen and Codexis. Broad incumbents are Novozymes (Novonesis), WuXi Biologics, Ginkgo Bioworks, AGC Biologics and Thermo Fisher Scientific (CDMO services). Emerging players are Bota Bio and Dyadic International.

Does Solar Biotech have an API?

No public API is recorded for Solar Biotech.

What industry is Solar Biotech in?

Solar Biotech's product category is Contract Biomanufacturing (CDMO) Services. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AgFunderNewsExclusive: Ex-Novozymes exec acquires assets of biomanufacturing specialists Solar Biotech, NoblegenPictor Biotech, led by ex-Novozymes executive Peter Rosholm, acquired Solar Biotech's assets in a bankruptcy auction, outbidding Ingredion's $15.2M bid with $20M. Rosholm plans to retain all US staff and invest substantially to expand capacity. Solar Biotech founder Alex Berlin will remain CEO, with operations centralized in Virginia.DailydacPUBLIC NOTICE OF CHAPTER 11 SALE: Solar Biotech, Inc.Solar Biotech, Inc. has filed for Chapter 11 bankruptcy and is seeking buyers for its assets through a stalking horse bid of $15.7 million, citing cash flow difficulties resulting from overexpansion despite prior profitability. The company, which operates biomanufacturing facilities in Virginia and Canada, aims to restructure its debt and find a strategic partner by the September 4, 2024 deadline.NewtechfoodsNEW TECH FOODSSolar Biotech, a US-based biomanufacturing provider, has acquired Canadian digital biology company Noblegen, which now operates as Solar Biotech Canada. The combined entity will utilize its Peterborough facility to support start-up innovators in developing and scaling processes for microorganisms like bacteria and fungi. This acquisition aims to bolster the bio-economy by providing industrial partners with expanded capacity and complementary intellectual property.TrentarthurNoblegen's Acquisition By Solar Biotech Bolsters Hope For Partnership With Trent's Cleantech CommonsSolar Biotech acquired Peterborough-based Noblegen on July 25, with founder Adam Noble joining as Chief Visionary Officer to secure funding and investments. The combined entity, operating as Solar Biotech Canada, plans to expand fermentation capacity tenfold via a new GEN2 facility and continue exploring tenancy at Trent University's Cleantech Commons. This acquisition aims to leverage Noblegen's bioprocessing expertise for industrial partners following years of financial struggles and staff reductions.TrentuFuture Cleantech Commons Tenant Announces AcquisitionU.S. biotechnology company Solar Biotech has acquired Canadian firm Noblegen Inc., which will operate as Solar Biotech Canada to combine strengths in microbiology and biomanufacturing. The new entity plans to build a GEN2 facility with over two million litres of fermentation capacity at Cleantech Commons in Peterborough, leveraging existing infrastructure at Trent University.Wildeboer Dellelce LLPSolar Biotech Inc. Completes Acquisition of Noblegen Inc.Solar Biotech Inc. has completed the acquisition of Noblegen Inc., an advanced digital biology company based in Peterborough, Ontario. The acquired entity will be renamed Solar Biotech Canada and will serve as Solar's food-grade-certified biomanufacturing and research & development hub.StlawyersSolar Biotech acquires biotech company Noblegen: Employee rightsSolar Biotech has acquired Peterborough-based Noblegen, which will now operate as Solar Biotech Canada to continue its biomanufacturing and R&D operations. The acquisition integrates Noblegen's capabilities in plant-based foods and bioproducts with Solar Biotech's microbiology strengths under the leadership of Adam Noble and Alex Berlin. The transaction involves specific employee rights regarding severance pay for staff not retained by the new entity.PR NewswireSolar Biotech, Inc. Receives Investment from Ingredion Inc. to Accelerate the Development of its Advanced SynBio Bioprocessing Technologies and Proprietary SynBio Products PipelineIngredion Inc. has invested in Solar Biotech, Inc. to accelerate the development of its advanced synthetic biology bioprocessing technologies and proprietary product pipeline. The investment, facilitated by Young America Capital, will support Solar Biotech's expansion at its facility in Norton, Virginia, aiming to introduce sustainable, cell-based biomanufacturing products to the FoodTech industry.foodingredientsfirst.com“Bringing heme protein to fruition”: Motif Foodworks and Solar Biotech expand plant-based partnershipMotif Foodworks and Solar Biotech expanded their partnership to scale production of Hemami, a yeast-derived heme protein for plant-based foods. The protein, approved by the FDA, provides umami and meaty aroma, and the companies plan to use precision fermentation for industrial-scale manufacturing.vegconomistSolar Biotech Expands Partnership With Motif Foodworks After “Groundbreaking” HEMAMI RevealSolar Biotech expanded its partnership with Motif FoodWorks after Motif launched HEMAMI, a yeast-derived heme protein. The partnership, begun in 2020, will support sampling and new plant-based products. Both companies expect to use precision fermentation to advance sustainable food options.